Kratom Dependence and Withdrawal: What Buyers Should Know Before a First Order

What federal health agencies say about dependence and withdrawal, the warning signs worth taking seriously, and where to get confidential help.

Short answer: yes, kratom can cause physical dependence, and people who stop after regular use can go through withdrawal. The FDA lists physical dependence and withdrawal among the opioid-type effects kratom compounds may produce, and the National Institute on Drug Abuse (NIDA) says studies suggest people may have mild to moderate withdrawal symptoms when they stop regular use. There is no FDA-approved kratom product and no established safe dose.

This page is not here to talk anyone into or out of a purchase. It is the risk information that should sit next to any kratom buying guide, ours included. Read it before a first order, not after.

What the federal agencies actually say

Three federal sources cover this ground, and they don't all strike the same tone. That's worth knowing, because sellers tend to quote whichever line suits them.

FDA: dependence is a listed risk

The FDA's kratom page (last updated December 2, 2025) says there are no FDA-approved kratom drug products, that kratom is not lawfully marketed as a drug, dietary supplement or food additive, and that the agency "continues to warn consumers not to use kratom because of the risk of serious adverse events." Among those risks it names liver toxicity, seizures and substance use disorder. It lists physical dependence and withdrawal among the classic opioid-related effects kratom compounds may produce, and it notes reports of newborns showing withdrawal signs after exposure during pregnancy.

NIDA: real, often milder than opioids, still unresolved

NIDA's kratom page (updated March 11, 2026) is more measured. It says the two main kratom compounds, mitragynine and 7-hydroxymitragynine (7-OH), activate mu-opioid receptors, but that the resulting effects only partly resemble drugs like heroin or oxycodone. It says a minority of surveyed users report withdrawal, and a smaller minority report symptoms of substance use disorder. It also says there are currently no approved medical therapies for kratom withdrawal or kratom-related substance use disorder.

NCCIH: addiction potential and withdrawal

The NIH's complementary-health center says kratom "may have the potential to be addictive" and that regular users may have withdrawal symptoms if they stop. It also flags rare but serious reports of seizures, high blood pressure and liver problems.

Put together: the agencies disagree on emphasis, not on the basic fact. Dependence and withdrawal are documented. How likely they are for any one person is not something anyone can promise you, and no vendor label can either.

Why concentrated products deserve extra caution

Most of the federal concern in 2025 and 2026 has focused on concentrated and semi-synthetic products rather than plain leaf. The FDA describes 7-OH as having substantially greater mu-opioid receptor potency than mitragynine and morphine, and says it makes up less than 2% of the alkaloids in natural leaf. In July 2025 the FDA recommended scheduling certain 7-OH products, saying the action was not focused on natural leaf. In 2026 the DEA moved to temporarily schedule 7-OH above a threshold, plus a related compound called mitragynine pseudoindoxyl. Our 7-OH scheduling explainer covers that in detail.

For a buyer, the practical point is simple. A product that is labeled or marketed for strength, or one with no lab report, is a different risk from a tested leaf product. Our guide to spotting synthetic 7-OH shows how to tell from the label and the certificate of analysis (COA).

Warning signs worth taking seriously

These are general signs that use is moving toward dependence. They are not a diagnosis. NIDA notes that the DSM-5, the manual clinicians use, has no kratom-specific diagnosis, so a clinician will look at the overall pattern.

• You use it to stop feeling unwell rather than for the reason you started.
• You feel noticeably worse (restless, irritable, unable to sleep, sick) when you skip it or run out.
• You need more, or a stronger format, to get what you used to get from less.
• You've tried to cut back and couldn't, or you plan around making sure you don't run out.
• Spending, work, sleep or relationships are taking hits you'd rather not admit.
• You're combining it with alcohol, opioids, benzodiazepines or other sedatives. Federal reviews of kratom-related deaths found other drugs involved in most cases.

If two or more of these sound familiar, that is a reason to talk to a doctor now, not later.

A pre-order checklist

If you're still deciding, run through this first. None of it is about dose, and none of it makes kratom safe. It's about not walking in blind.

1. Check your medications with a pharmacist. The NCCIH says more research is needed on drug interactions, and the FDA notes that reported deaths usually involved other drugs. Bring every prescription, over-the-counter product and supplement you take.
2. Know your personal risk factors. A history of substance use disorder, pregnancy, liver disease or a seizure disorder are all reasons to talk to a clinician first.
3. Check the law where you live. Some states ban kratom outright and many cities and counties restrict it. Start with our state-by-state legality guide. Kansas and Tennessee both moved against kratom in 2026; see the Kansas and Tennessee pages.
4. Check drug-testing exposure. If your job tests, read kratom and drug tests before anything else.
5. Only buy products with a lot-matched lab report. If a product has no COA for your lot, you don't know what's in it.
6. Decide in advance what would make you stop. Write down which of the warning signs above would be your line. It is easier to keep a rule you set before you started.

The FDA has not approved kratom for any use, there is no established safe dose, and anyone considering it should talk to a clinician first.

If you want to stop

We are not going to give a taper schedule, and you should be wary of anyone online who does. NIDA says there are no approved treatments specifically for kratom withdrawal. That doesn't mean there's no help. It means the plan should come from a clinician who knows your history and what else you take.

• Start with your doctor. Be specific: the product, the format (powder, capsule, liquid extract), how often, and anything else you use. Bring the label or a photo of it.
• SAMHSA National Helpline: 1-800-662-4357. Free, confidential, 24/7 treatment referral and information.
• FindTreatment.gov is SAMHSA's locator for treatment facilities near you.
• If someone is in danger (unresponsive, breathing slowly, having a seizure), call 911. For a possible poisoning, Poison Help is 1-800-222-1222 and connects you to your local poison center.
• If you're in crisis or thinking about harming yourself, call or text 988.

What vendor marketing leaves out

You'll see vendor sites describe kratom as "natural," "plant-based" or "a traditional botanical." All of that can be true and still say nothing about dependence. Natural origin is not a safety claim. The FDA has not evaluated any vendor's health statements, and a product page that implies kratom treats pain, anxiety or opioid withdrawal is making a claim no regulator has accepted. Our vendor red-flags guide lists the phrases to watch for.

Two other points to keep in mind:

• Strength is a selling point and a risk at the same time. Extract shots and concentrated tablets are sold on potency. Higher-alkaloid formats are exactly where the regulatory concern has focused.
• Subscriptions make stopping harder. Auto-ship removes the moment where you'd decide whether to reorder. If you subscribe to anything, know how to cancel before your first charge.

Sources

• FDA, "FDA and Kratom" (updated December 2, 2025): fda.gov
• NIDA, "Kratom" (updated March 11, 2026): nida.nih.gov
• NCCIH, "Kratom": nccih.nih.gov
• HHS press release on FDA's 7-OH scheduling recommendation (July 29, 2025): hhs.gov
• Poison Help line (HRSA): poisonhelp.hrsa.gov
• SAMHSA treatment locator: findtreatment.gov